AN; Zhiqiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for AN; Zhiqiang.The latest application filed is for "multimeric sars-cov-2 binding molecules and uses thereof".

Company Profile

12.33.40

AN; Zhiqiang - Houston TX
An; Zhiqiang - Pearland TX
An; Zhiqiang - Dallas TX
An; Zhiqiang - Ambler PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multimeric Sars-cov-2 Binding Molecules And Uses Thereof App 20220267415 - KU; Zhiqiang ; et al.	2022-08-25
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer Grant 11,377,491 - Liao , et al. July 5, 2	2022-07-05
Monoclonal Antibodies Against Endotrophin And The Use Thereof App 20220056124 - ZHANG; Ningyan ; et al.	2022-02-24
CMV neutralizing antigen binding proteins Grant 11,230,591 - Fu , et al. January 25, 2	2022-01-25
Novel Lilrb4 Antibodies And Uses Thereof App 20210371518 - AN; Zhiqiang ; et al.	2021-12-02
Nmes1 Antibodies And Methods Of Use Thereof App 20210371508 - ZHANG; Ningyan ; et al.	2021-12-02
HER3 specific monoclonal antibodies for diagnostic and therapeutic use Grant 11,174,320 - Zhang , et al. November 16, 2	2021-11-16
Methods For Identifying Lilrb-blocking Antibodies App 20210349096 - ZHANG; Chengcheng ; et al.	2021-11-11
Connexin (cx) 43 Hemichannel-binding Antibodies And Uses Thereof App 20210253680 - Jiang; Jean X. ; et al.	2021-08-19
Leptin Antibodies App 20210188970 - An; Zhiqiang ; et al.	2021-06-24
Targeting Lilrb4 With Car-t Or Car-nk Cells In The Treatment Of Cancer App 20210179687 - ZHANG; Chengcheng ; et al.	2021-06-17
Egfl6 Specific Monoclonal Antibodies And Methods Of Their Use App 20210130450 - ZHANG; Ningyan ; et al.	2021-05-06
Endotrophin neutralization and use thereof Grant 10,975,142 - Scherer , et al. April 13, 2	2021-04-13
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies Grant 10,889,637 - Jiang , et al. January 12, 2	2021-01-12
EGFL6 specific monoclonal antibodies and methods of their use Grant 10,875,912 - Zhang , et al. December 29, 2	2020-12-29
Linkers For Antibody Drug Conjugates App 20200115326 - TSUCHIKAMA; Kyoji ; et al.	2020-04-16
Anti-lilrb Antibodies And Their Use In Detecting And Treating Cancer App 20200079851 - ZHANG; Chengcheng ; et al.	2020-03-12
Her3 Specific Monoclonal Antibodies For Diagnostic And Therapeutic Use App 20200055954 - ZHANG; Ningyan ; et al.	2020-02-20
Endotrophin Neutralization And Use Thereof App 20200024333 - SCHERER; Philipp Erich ; et al.	2020-01-23
Anti-LILRB antibodies and their use in detecting and treating cancer Grant 10,501,538 - Zhang , et al. Dec	2019-12-10
Connexin (cx) 43 Hemichannel-binding Antibodies And Uses Thereof App 20190359696 - Jiang; Jean X. ; et al.	2019-11-28
Anti-lair1 Antibodies And Their Uses App 20190338026 - LIAO; X. Charlene ; et al.	2019-11-07
HER3 specific monoclonal antibodies for diagnostic and therapeutic use Grant 10,358,501 - Zhang , et al.	2019-07-23
Cmv Neutralizing Antigen Binding Proteins App 20190106481 - Fu; Tong-Ming ; et al.	2019-04-11
Endotrophin neutralization and use thereof Grant 10,221,235 - Scherer , et al.	2019-03-05
Egfl6 Specific Monoclonal Antibodies And Methods Of Their Use App 20190031751 - ZHANG; Ningyan ; et al.	2019-01-31
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 10,106,617 - Nash , et al. October 23, 2	2018-10-23
Anti-lilrb Antibodies And Their Use In Detecting And Treating Cancer App 20180086829 - ZHANG; Chengcheng ; et al.	2018-03-29
Her3 Specific Monoclonal Antibodies For Diagnostic And Therapeutic Use App 20180066066 - ZHANG; Ningyan ; et al.	2018-03-08
CMV neutralizing antigen binding proteins Grant 9,868,777 - Fu , et al. January 16, 2	2018-01-16
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20170369579 - Nash; Andrew Donald ; et al.	2017-12-28
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,777,062 - Nash , et al. October 3, 2	2017-10-03
Endotrophin Neutralization And Use Thereof App 20170267749 - SCHERER; Philipp Erich ; et al.	2017-09-21
HER3 specific monoclonal antibodies for diagnostic and therapeutic use Grant 9,725,520 - Zhang , et al. August 8, 2	2017-08-08
Endotrophin neutralization and use thereof Grant 9,605,057 - Scherer , et al. March 28, 2	2017-03-28
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20160362497 - Nash; Andrew Donald ; et al.	2016-12-15
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,371,388 - Nash , et al. June 21, 2	2016-06-21
Cmv Neutralizing Antigen Binding Proteins App 20160130327 - Fu; Tong-Ming ; et al.	2016-05-12
Her3 Specific Monoclonal Antibodies For Diagnostic And Therapeutic Use App 20160032011 - ZHANG; Ningyan ; et al.	2016-02-04
Anti-ADDL antibodies and uses thereof Grant 8,889,138 - Acton , et al. November 18, 2	2014-11-18
High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20140056915 - Nash; Andrew Donald ; et al.	2014-02-27
Anti-IL-13R.alpha.1 antibodies and their uses thereof Grant 8,613,925 - Nash , et al. December 24, 2	2013-12-24
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 8,568,722 - Nash , et al. October 29, 2	2013-10-29
Anti-ADDL monoclonal antibody and use thereof Grant 8,420,093 - Kinney , et al. April 16, 2	2013-04-16
Anti-ADDL antibodies and uses thereof Grant 8,383,113 - Acton , et al. February 26, 2	2013-02-26
Antibodies Specific For Dkk-1 App 20120201835 - An; Zhiqiang ; et al.	2012-08-09
Anti-ADDL Antibodies and Uses Thereof App 20120171224 - Acton; Paul ; et al.	2012-07-05
Anti-ADDL Monoclonal Antibody and Use Thereof App 20120164158 - KINNEY; GENE ; et al.	2012-06-28
Antibody antagonists of interleukin-13 receptor .alpha.1 Grant 8,207,304 - Nash , et al. June 26, 2	2012-06-26
Anti-ADDL antibodies and uses thereof Grant 8,128,930 - Acton , et al. March 6, 2	2012-03-06
Anti-ADDL monoclonal antibody and use thereof Grant 8,105,593 - Kinney , et al. January 31, 2	2012-01-31
Antibodies specific for Dkk-1 Grant 7,994,293 - An , et al. August 9, 2	2011-08-09
Anti-ADDL Antibodies and Uses Thereof App 20110159013 - Acton; Paul ; et al.	2011-06-30
Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof App 20110052597 - Nash; Andrew Donald ; et al.	2011-03-03
High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 App 20100285035 - Nash; Andrew Donald ; et al.	2010-11-11
Anti-ADDL Antibodies and Uses Thereof App 20100272714 - Acton; Paul ; et al.	2010-10-28
Anti-addl antibodies and uses thereof Grant 7,811,563 - Acton , et al. October 12, 2	2010-10-12
Anti-ADDL monoclonal antibody and use thereof App 20100239597 - Kinney; Gene ; et al.	2010-09-23
Anti-ADDL antibodies and uses thereof Grant 7,780,963 - Acton , et al. August 24, 2	2010-08-24
High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 7,754,213 - Nash , et al. July 13, 2	2010-07-13
ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n App 20100166772 - Anderson; Annaliesa S. ; et al.	2010-07-01
Anti-ADDL monoclonal antibody and use thereof Grant 7,731,962 - Kinney , et al. June 8, 2	2010-06-08
Antibody Antagonists of Interleukin-13 Receptor Alpha1 App 20090285799 - Nash; Andrew Donald ; et al.	2009-11-19
Antibodies specific for DKK-1 App 20080193449 - An; Zhiqiang ; et al.	2008-08-14
High affinity antibody antagonists of interleukin-13 receptor alpha 1 App 20080166343 - Nash; Andrew Donald ; et al.	2008-07-10
Anti-ADDL monoclonal antibody and use thereof App 20070081998 - Kinney; Gene ; et al.	2007-04-12
Anti-ADDL antibodies and uses thereof App 20060228349 - Acton; Paul ; et al.	2006-10-12